切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2017, Vol. 04 ›› Issue (03) : 186 -189. doi: 10.3877/cma.j.issn.2095-8773.2017.03.11

所属专题: 专题评论 文献

论著

Caprini和Rogers风险评估模型联合使用可以提高胸外科术后患者筛选静脉血栓栓塞症的准确性
田博1, 宋春凤1, 李辉1,*(), 傅毅立1, 张文谦1, 胡晓星1, 陈其瑞1, 游宾1, 陈硕1, 李彤1, 胡滨1, 侯生才1   
  1. 1. 100020 首都医科大学附属北京朝阳医院胸外科
  • 收稿日期:2017-05-10 出版日期:2017-08-28
  • 通信作者: 李辉

The combination of Caprini and Rogers risk assessment models can improve the accuracy of screening for venous thromboembolism in patients undergoing thoracic surgery

Bo Tian1, Chunfeng Song1, Hui Li1,(), Yili Fu1, Wenqian Zhang1, Xiaoxing Hu1, Qirui Chen1, Bin You1, Shuo Chen1, Tong Li1, Bin Hu1, Shengcai Hou1   

  1. 1. Department of Thoracic Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
  • Received:2017-05-10 Published:2017-08-28
  • Corresponding author: Hui Li
  • About author:
    Corresponding author: Li Hui, Email:
引用本文:

田博, 宋春凤, 李辉, 傅毅立, 张文谦, 胡晓星, 陈其瑞, 游宾, 陈硕, 李彤, 胡滨, 侯生才. Caprini和Rogers风险评估模型联合使用可以提高胸外科术后患者筛选静脉血栓栓塞症的准确性[J]. 中华胸部外科电子杂志, 2017, 04(03): 186-189.

Bo Tian, Chunfeng Song, Hui Li, Yili Fu, Wenqian Zhang, Xiaoxing Hu, Qirui Chen, Bin You, Shuo Chen, Tong Li, Bin Hu, Shengcai Hou. The combination of Caprini and Rogers risk assessment models can improve the accuracy of screening for venous thromboembolism in patients undergoing thoracic surgery[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2017, 04(03): 186-189.

目的

验证Caprini和Rogers风险评估模型在胸外科手术后患者中筛选静脉血栓栓塞症(VTE)的有效性。

方法

采用单中心回顾性研究,以2016年7—12月首都医科大学附属北京朝阳医院胸外科行手术治疗的194例患者为样本,以Caprini和Rogers风险评估模型对所有患者进行回顾性血栓风险评分,并通过Logistic二分类回归分析得到Caprini和Rogers联合使用后的预测概率值,分别绘制受试者工作特征(ROC)曲线,计算曲线下面积(AUC),进行两两比较,以Youden指数最大的分界点作为最佳诊断分界点。

结果

胸外科术后总的VTE发生率为13.4%。Caprini模型AUC为(0.713±0.043,P<0.001),Rogers模型AUC为(0.577±0.062,P=0.207),预测概率模型AUC为(0.730±0.041,P<0.001)。Caprini模型分别与Rogers和预测概率模型AUC比较,差异均无统计学意义(P>0.05);但预测概率模型较Rogers模型AUC显著增加,差异有统计学意义(P=0.015)。Caprini模型在Youden指数为0.393时,敏感度为0.923,特异度为0.47;Rogers模型在Youden指数为0.135时,敏感度为0.385,特异度为0.75;预测概率模型在Youden指数为0.444时,敏感度为0.962,特异度为0.48。

结论

Caprini和Rogers风险评估模型联合使用可以提高胸外科手术后患者筛选VTE的准确性。

Objective

To verify the efficacy of Caprini and Rogers risk assessment models of screening for venous thromboembolism (VTE) in patients undergoing thoracic surgery.

Methods

A single center retrospective study was performed in the department of thoracic surgery in Beijing Chao-Yang Hospital affiliated to Capital Medical University from July to December in 2016. The Caprini and Rogers risk score were recorded retrospectively for each patient. Meanwhile, by using of logistic bivariate regression analysis, we have obtained the predicted probability of Caprini and Rogers in combination diagnosis. We have drawn receiver operating characteristic curves (ROC) respectively, and calculated the area under the curve (AUC), then we have done pairwise comparison severally. The Youden index was taken as the cutoff point.

Results

The total incidence of VTE after thoracic surgery was 13.4%. The AUC for the the Caprini model, the Rogers model and the predictive probability model were 0.713±0.043 (P<0.001), 0.577±0.062 (P=0.207) and 0.730±0.041 (P<0.001) respectively. There was no significant difference in AUC between Caprini model and the other two models (P>0.05); while the AUC of the predictive probability model was significantly higher than that of the Rogers model (P=0.015). Caprini model had a sensitivity of 0.923 and a specificity of 0.47 when the Youden index was 0.393. The Rogers model had a sensitivity of 0.385 and a specificity of 0.75 when the Youden index was 0.135. The predictive probability model had a sensitivity of 0.962 and a specificity of 0.48 when the Youden index was 0.444.

Conclusions

The combined use of Caprini and Rogers risk assessment model can improve the accuracy of screening for venous thromboembolism in patients undergoing thoracic surgery.

图1 Caprini、Rogers和预测概率模型的ROC曲线
表1 三种模型的Youden指数及其对应的敏感度和特异度
1
Bagot CN, Arya R. Virchow and his triad: a question of attribution[J]. Br J Haematol, 2008, 143(2): 180-190.
2
Goldhaber SZ. Risk factors for venous thromboembolism[J]. J Am Coll Cardiol, 2010, 56(1): 1-7.
3
Spencer FA, Emery C, Lessard D, et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism[J]. J Gen Intern Med, 2006, 21(7): 722-727.
4
Nelson RE, Grosse SD, Waitzman NJ, et al. Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010[J]. Thromb Res, 2015, 135(4): 636-642.
5
Merkow RP, Bilimoria KY, McCarter MD, et al. Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis[J]. Ann Surg, 2011, 254(1): 131-137.
6
Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project[J]. Ann Surg, 2006, 243(1): 89-95.
7
Caprini JA. Thrombosis risk assessment as a guide to quality patient care[J]. Dis Mon, 2005, 51(2-3): 70-78.
8
Rogers SO, Kilaru RK, Hosokawa P, et al. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study[J]. J Am Coll Surg, 2007, 204(6): 1211-1121.
9
Hachey KJ, Sterbling H, Choi DS, et al. Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol[J]. J Am Coll Surg, 2016, 222(6): 1019-1027.
10
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149(2): 315-352.
11
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e227S-e277S.
12
Hachey KJ, Hewes PD, Porter LP, et al. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer[J]. J Thorac Cardiovasc Surg, 2016, 151(1): 37-44.e1.
13
Hewes PD, Hachey KJ, Zhang XW, et al. Evaluation of the Caprini Model for Venothromboembolism in Esophagectomy Patients[J]. Ann Thorac Surg, 2015, 100(6): 2072-2078.
[1] 蒋钰辉, 刘小玉, 盛健, 周逸鸣, 戴希勇. 纤维板钙化结核性脓胸外科治疗临床分析:一项基于倾向性评分匹配的回顾性队列研究[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(03): 180-186.
[2] 林映雪, 梁朝阳, 刘阳, 李宬润. 数字3D技术在胸外科中的发展及应用[J]. 中华腔镜外科杂志(电子版), 2021, 14(06): 379-384.
[3] 孙莉莉, 李晓强, 张明, 朱健, 黄佃. 非编码RNAs调控内皮祖细胞对静脉血栓的影响[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(03): 181-185.
[4] 陈慧娟, 张艳, 李立, 王红莉, 赵思萌, 李冰冰, 赵佳音, 孔祥燕. 预防骨科患者静脉血栓栓塞症的循证实践[J]. 中华肩肘外科电子杂志, 2022, 10(02): 162-168.
[5] 鲁春蕾, 刘昌华. 特发性膜性肾病并发静脉血栓栓塞症的研究进展[J]. 中华肾病研究电子杂志, 2020, 09(05): 220-223.
[6] 史亚东, 顾建平. 无症状肺栓塞的诊断与治疗进展[J]. 中华介入放射学电子杂志, 2023, 11(02): 155-158.
[7] 彭波, 卡德尔江·木沙, 刘娜, 于长辉, 喻天启, 范红友, 李智. 新疆克州静脉血栓栓塞症的危险因素及发病特征分析[J]. 中华介入放射学电子杂志, 2022, 10(03): 250-253.
[8] 杨丁, 牟巨伟, 高树庚. 胸外专科医师培训体系演进简述[J]. 中华胸部外科电子杂志, 2023, 10(03): 188-194.
[9] 刘铠宾, 杨异. 单中心787例胸外伤患者静脉血栓栓塞症危险因素分析与风险预测模型构建[J]. 中华胸部外科电子杂志, 2023, 10(02): 57-62.
[10] 殷怡维, 焦正, 方文涛. 胸外科术前基础疾病的药物管理[J]. 中华胸部外科电子杂志, 2022, 09(04): 255-263.
[11] 杨洋, 李志刚. 达芬奇机器人手术在胸外科的应用[J]. 中华胸部外科电子杂志, 2022, 09(04): 230-234.
[12] 赵珂, 王桂阁, 张家齐, 周梦馨, 郭超, 陈野野, 黄诚, 饶可, 李单青. 胸外科手术患者出院后90 d内非计划再次入院分析[J]. 中华胸部外科电子杂志, 2022, 09(02): 91-99.
[13] 方文涛. 从技术精进到理念超越——《中华胸部外科电子杂志》2022年第一期导读[J]. 中华胸部外科电子杂志, 2022, 09(02): 109-110.
[14] 孙益鑫, 崔松平, 李辉, 刘毅, 柯立晖. 基于倾向性评分匹配法探讨肺外科围手术期静脉血栓栓塞症预防性抗凝的有效性及安全性[J]. 中华胸部外科电子杂志, 2021, 08(01): 21-35.
[15] 黎鑫, 艾克拜尔·艾力, 克力木·阿不都热依木. 腹腔镜食管裂孔疝修补术围手术期静脉血栓栓塞症的危险因素和防治策略[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 42-45.
阅读次数
全文


摘要